← FDA ENFORCEMENT
D-0356-2025Class II

Somerset Therapeutics Private Limited

Recalling firm
Somerset Therapeutics Private Limited
Product type
Drug
Status
Ongoing
Report date
2025-04-16
Distribution
U.S. Nationwide
Firm state
N/A
Product quantity
4956 vials
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental Monitoring
Reason for recall

Lack of Assurance of Sterility: Media fill with bacterial contamination

Product description

Haloperidol Decanoate Injection 50mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka India, Manufactured for: BluePoint Laboratories NDC 68001-580-41

Code / lot info

A240467B, exp. date 07/2026

Other recalls SPEQ maps to Environmental Monitoring
2026-07-22Class IArgon Medical Devices, Inc2026-07-22Class IIChiesi USA, Inc.2026-07-22Class IICareFusion 213, LLC2026-07-22Class IIOlympus Corporation of the Americas
See all Environmental Monitoring recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.